This study attempted to elucidate the possible mechanism of
magnesium sulfate (MgSO4 ) administration on reducing
insulin resistance in type 2 diabetic rats. Fifty Wistar rats were divided into five groups: NDC was fed the normal diet, CD received high-fat diet with 35 mg/kg of
streptozotocin, CD-Mg animals received MgSO4 via
drinking water, CD-Ins1, and CD-Ins2 animals treated with low or high dose of
insulin.
Body weight and
blood glucose levels were measured weekly. Intraperitoneal
glucose tolerance test (IPGTT),
insulin tolerance test, and metabolic cage assessment were performed monthly. After 12 weeks, the hyperinsulinemic-euglycemic clamp was performed for all animals and blood sample was taken to measure
glycated hemoglobin (HbA1c), plasma
insulin,
glucagon,
calcium, and
magnesium levels. Liver and gastrocnemius muscle were isolated to measure
glucagon receptor (GR),
Glucose 6 phosphatase (G6Pase),
Phosphoenolpyruvate carboxykinase (Pepck) and
Glucose transporter 4 (Glut4) genes expression and
GLUT4 protein translocation into the cell membrane. Consuming of high-fat diet generated
insulin-resistant rats.
Magnesium or
insulin therapy altered
insulin resistance,
blood glucose, IPGTT, gluconeogenesis pathway, GR,
body weight, the percentage of body fat, and HbA1C in diabetic rats. Administrations of MgSO4 or
insulin in
Type 2 diabetes mellitus animals increase GLUT4 gene and
protein expression. Mg could improve
glucose tolerance via stimulation of Glut4 gene expression and translocation and also suppression of the gluconeogenesis pathway and GR gene expression. Mg also increased
glucose infusion rate and displayed beneficial effects in the treatment of
glucose metabolism and improved
insulin resistance.